Investegate |CureVac Announcements | CureVac: CureVac Expands Lead RNA Cancer Program Phase 1 Trial in Advanced Melanoma
DGAP-News: CureVac / Key word(s): Study CureVac Expands Lead RNA Cancer Program Phase 1 Trial in Advanced Melanoma 04.02.2021 / 13:10 CureVac Expands Lead RNA Cancer Program Phase 1 Trial in Advanced Melanoma - - Trial expansion focuses on advanced melanoma, an indication of high medical need TÜBINGEN, Germany / BOSTON, USA - February 4, 2021 - CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), today announced the start of an expansion of the ongoing Phase 1 study with its lead RNA-...
Source: investegate.co.uk